Michele L. Obert

FDA investigator

Appears on 6 documents from 2012 to 2019, mostly at sites in Kansas. Most often cites control of microbiological contamination (21 CFR 211.113).

6
Documents on file
5.7
Observations per 483
2012
First seen
2019
Most recent

What they cite most

From 35 observations

Activity by year

2012: 1, 2014: 1, 2015: 1, 2017: 2, 2019: 1

Where

Kansas 3 · Missouri 2 · Iowa 1

Is Michele L. Obert coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 AML Riverside, LLCApr 3, 2019 · Fort Dodge, Iowa
483 Triad Isotopes Inc.Jul 3, 2017 · Kansas City, Missouri
483 Meridian Medical Technologies, Inc. a Pfizer CompanyMar 24, 2017 · Brentwood, Missouri
483 Bayer Health Care LLCJul 30, 2015 · Shawnee, Kansas
483 Perry DrugSep 9, 2014 · Overland Park, Kansas
483 Hospira Boulder, Inc.Jan 4, 2012 · Mcpherson, Kansas

About this profile

What does Michele L. Obert inspect?

Michele L. Obert appears on 6 documents on file covering 6 sites, mostly in Kansas.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 820.30 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michele L. Obert is dated Apr 3, 2019.